These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4991058)

  • 1. Ethosuximide blood levels in epileptics.
    Haerer AF; Buchanan RA; Wiygul FM
    J Clin Pharmacol J New Drugs; 1970; 10(6):370-4. PubMed ID: 4991058
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood serotonin in untreated petit-mal epileptics and influence of efficient treatment with either ethosuximide or valproate.
    Volanschi D; Luca N; HaĊ£egan D; Ionescu G
    Neurol Psychiatr (Bucur); 1982; 20(1):67-70. PubMed ID: 6803347
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved control of epilepsy by monitoring plasma ethosuximide.
    Sherwin AL; Robb JP; Lechter M
    Arch Neurol; 1973 Mar; 28(3):178-81. PubMed ID: 4631034
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ethosuximide in treatment of petit mal epilepsy].
    Kiehi Y; Ando J
    No To Shinkei; 1965 Aug; 17(8):831-40. PubMed ID: 4957471
    [No Abstract]   [Full Text] [Related]  

  • 5. [Catamnestic study of a series of cases of infantile epilepsy in relation to treatment with ethosuccinimide].
    Bertamino F; Luciano L; De Negri M
    Riv Neurol; 1973; 43(4):282-6. PubMed ID: 4205736
    [No Abstract]   [Full Text] [Related]  

  • 6. [Psychiatric and psychologic effects of ethosuximide treatment of epileptics].
    Roger J; Grangeon H; Gueyj J; Lob H
    Encephale; 1968; 57(5):407-38. PubMed ID: 4976579
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with a combination of ethosuximide and mepacrine (Acrisuxin) in the treatment of chronic epileptic seizures in children].
    Hohenauer I; Schmoigl S
    Padiatr Padol; 1972; 7(4):380-3. PubMed ID: 4628247
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with suxilep in childhood epilepsy].
    Degen R
    Dtsch Gesundheitsw; 1969 Jan; 24(3):116-21. PubMed ID: 4989500
    [No Abstract]   [Full Text] [Related]  

  • 9. [Our experiences with suximide (Zarontin) therapy of some childhood forms of epilepsy].
    Hajnsek F
    Neuropsihijatrija; 1963; 11(3):363-74. PubMed ID: 4965286
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal).
    Callaghan N; O'Hare J; O'Driscoll D; O'Neill B; Daly M
    Dev Med Child Neurol; 1982 Dec; 24(6):830-6. PubMed ID: 6818076
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethosuximide pharmacokinetics in a pregnant patient and her newborn.
    Koup JR; Rose JQ; Cohen ME
    Epilepsia; 1978 Dec; 19(6):535-9. PubMed ID: 104867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid versus ethosuximide in the treatment of absence seizures.
    Sato S; White BG; Penry JK; Dreifuss FE; Sackellares JC; Kupferberg HJ
    Neurology; 1982 Feb; 32(2):157-63. PubMed ID: 6798490
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trials with ethosuximide (Zarontin) in therapy-resistant epileptics].
    Sato T; Kondo Y; Matsuo T; Iwata H; Okuyama Y; Aoki Y
    No To Shinkei; 1965 Sep; 17(9):958-64. PubMed ID: 4953431
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with clinico-electroencephalographic studies on the action of zarontine in petit mal seizures in children].
    Samardzhiev AKh; Sirakov AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(10):1544-9. PubMed ID: 4970664
    [No Abstract]   [Full Text] [Related]  

  • 15. Valproic acid and ethosuximide interaction.
    Mattson RH; Cramer JA
    Ann Neurol; 1980 Jun; 7(6):583-4. PubMed ID: 6776874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is ethosuximide a risk factor for generalised tonic-clonic seizures in absence epilepsy?
    Schmitt B; Kovacevic-Preradovic T; Critelli H; Molinari L
    Neuropediatrics; 2007 Apr; 38(2):83-7. PubMed ID: 17712736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethosuximide in the treatment of absence (peptit mal) seizures.
    Browne TR; Dreifuss FE; Dyken PR; Goode DJ; Penry JK; Porter RJ; White BG; White PT
    Neurology; 1975 Jun; 25(6):515-24. PubMed ID: 805382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Plasma ethosuximide in epilepsy: clinical aid and illustration of principles.
    Stephenson JB; Clow DJ; Jamieson EC; Logan RW
    Arch Dis Child; 1974 May; 49(5):412. PubMed ID: 4834026
    [No Abstract]   [Full Text] [Related]  

  • 19. Once-daily ethosuximide in the treatment of absence epilepsy.
    Dooley JM; Camfield PR; Camfield CS; Fraser AD
    Pediatr Neurol; 1990; 6(1):38-9. PubMed ID: 2106890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in erythrocyte water content in subjects with "petit mal" epilepsy after treatment with alpha-ethyl-alpha-methyl-succinimide].
    Cassarino P; Falsaperla A; Papalia G
    Acta Neurol (Napoli); 1969; 24(3):416-30. PubMed ID: 4993840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.